639 BASECAMP-1: Leveraging HLA loss of heterozygosity in solid tumors by NGS to identify patients with relapsed solid tumors for future CEA and MSLN logic-gated Tmod™ CAR T-cell therapy

Diane Simeone; Maria Pia Morelli; J Randolph Hecht; Sandip Patel; Marwan Fakih; Kedar Kirtane; Theodore Welling; Sally Lau; Yi Lin; Mitesh Borad; Edward Garon; Sarah Larson; Shumei Kato; Peter Vu; Frederick Locke; Dae Won Kim; John Sunwoo; David Miklos; Matthew Frigault; Marcela Maus; Sarah Nikiforow; Caron Jacobson; Kirstin Liechty; Armen Mardiros; Ariane Lozac’hmeur; Karl Beutner; John Welch; Eric Ng; William Go; David Maloney; Scott Kopetz; Julian Molina

doi:10.1136/jitc-2022-SITC2022.0639

Article info

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

639 BASECAMP-1: Leveraging HLA loss of heterozygosity in solid tumors by NGS to identify patients with relapsed solid tumors for future CEA and MSLN logic-gated Tmod™ CAR T-cell therapy

Free

Authors

Diane Simeone New York University Langone Health, New York, NY, USA PubMed articles Google scholar articles
Maria Pia Morelli University of Texas MD Anderson Cancer, Houston, TX, USA PubMed articles Google scholar articles
J Randolph Hecht University of California at Los Angeles, Los Angeles, CA, USA PubMed articles Google scholar articles
Sandip Patel University of California San Diego, La Jolla, CA, USA PubMed articles Google scholar articles
Marwan Fakih City of Hope, Duarte, CA, USA PubMed articles Google scholar articles
Kedar Kirtane H. Lee Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Theodore Welling New York University Langone Health, New York, NY, USA PubMed articles Google scholar articles
Sally Lau New York University Langone Health, New York, NY, USA PubMed articles Google scholar articles
Yi Lin Mayo Clinic, Rochester, MN, USA PubMed articles Google scholar articles
Mitesh Borad Mayo Clinic Cancer Center, Scottsdale, AZ, USA PubMed articles Google scholar articles
Edward Garon University of California at Los Angeles, Los Angeles, CA, USA PubMed articles Google scholar articles
Sarah Larson University of California at Los Angeles, Los Angeles, CA, USA PubMed articles Google scholar articles
Shumei Kato University of California San Diego, La Jolla, CA, USA PubMed articles Google scholar articles
Peter Vu University of California San Diego, La Jolla, CA, USA PubMed articles Google scholar articles
Frederick Locke H. Lee Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Dae Won Kim H. Lee Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
John Sunwoo Massachusetts General Cancer Center, Boston, MA, USA PubMed articles Google scholar articles
David Miklos Stanford University School of Medicine, Palo Alto, CA, USA PubMed articles Google scholar articles
Matthew Frigault Massachusetts General Cancer Center, Boston, MA, USA PubMed articles Google scholar articles
Marcela Maus Massachusetts General Cancer Center, Boston, MA, USA PubMed articles Google scholar articles
Sarah Nikiforow Dana-Farber Cancer Institute, Boston, MA, USA PubMed articles Google scholar articles
Caron Jacobson Dana-Farber Cancer Institute, Boston, MA, USA PubMed articles Google scholar articles
Kirstin Liechty Tempus, Chicago, IL, USA PubMed articles Google scholar articles
Armen Mardiros A2 Biotherapeutics, Inc., Agoura Hills, CA, USA PubMed articles Google scholar articles
Ariane Lozac’hmeur Tempus, Chicago, IL, USA PubMed articles Google scholar articles
Karl Beutner Tempus, Chicago, IL, USA PubMed articles Google scholar articles
John Welch A2 Biotherapeutics, Inc., Agoura Hills, CA, USA PubMed articles Google scholar articles
Eric Ng A2 Biotherapeutics, Agoura Hills, CA, USA PubMed articles Google scholar articles
William Go A2 Biotherapeutics, Inc., Agoura Hills, CA, USA PubMed articles Google scholar articles
David Maloney Fred Hutchinson Cancer Research Center, Seattle, WA, USA PubMed articles Google scholar articles
Scott Kopetz University of Texas MD Anderson Cancer, Houston, TX, USA PubMed articles Google scholar articles
Julian Molina Mayo Clinic, Rochester, MN, USA PubMed articles Google scholar articles

Citation

Simeone D, Morelli MP, Randolph Hecht J, et al

639 BASECAMP-1: Leveraging HLA loss of heterozygosity in solid tumors by NGS to identify patients with relapsed solid tumors for future CEA and MSLN logic-gated Tmod™ CAR T-cell therapy

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0639

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password